Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions

被引:67
作者
Yozai, K [1 ]
Shikata, K [1 ]
Sasaki, M [1 ]
Tone, A [1 ]
Ohga, S [1 ]
Usui, H [1 ]
Okada, S [1 ]
Wada, J [1 ]
Nagase, R [1 ]
Ogawa, D [1 ]
Shikata, Y [1 ]
Makino, H [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 11期
关键词
D O I
10.1681/ASN.2004111011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recent studies suggested the involvement of inflammatory processes in the pathogenesis of diabetic nephropathy. Methotrexate (MTX), a folic acid antagonist, is widely used for the treatment of inflammatory diseases. Recently, it has been shown that treatment with low-dose MTX reduces the cardiovascular mortality in patients with rheumatoid arthritis, suggesting that MTX has anti-atherosclerotic effects via its anti-inflammatory actions. This study was designed to determine the anti-inflammatory effects of this agent on diabetic nephropathy. Diabetes was induced in Sprague-Dawley rats with streptozotocin, and MTX (0.5 or 1.0 mg/kg) was administered once a week for 8 wk. Treatment with MTX reduced urinary albumin excretion, mesangial matrix expansion, macrophage infiltration, expression of TGF-beta and type IV collagen, and intercellular adhesion molecule-1 in glomeruli. MTX also reduced the high glucose-induced NF-kappa B activation in vitro and in vivo. The results indicate that intermittent administration of MTX prevented renal injuries without changes in blood glucose level and BP in experimental diabetic rats. The protective effects of MTX are suggested to be mediated by its anti-inflammatory actions through inhibition of NF-kappa B activation and consequent reduction of intercellular adhesion molecule-1 expression and macrophage infiltration. The results suggest that anti-inflammatory agents might be beneficial for the treatment of diabetic nephropathy.
引用
收藏
页码:3326 / 3338
页数:13
相关论文
共 47 条
[1]  
ADLER S, 1994, J AM SOC NEPHROL, V5, P1165
[2]   Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation [J].
Altannavch, TS ;
Roubalová, K ;
Kucera, P ;
Andel, M .
PHYSIOLOGICAL RESEARCH, 2004, 53 (01) :77-82
[3]   Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis [J].
Chládek, J ;
Grim, J ;
Martínková, J ;
Simková, M ;
Vanìèková, J ;
Koudelková, V ;
Noièková, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) :147-156
[4]   Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study [J].
Choi, HK ;
Hernán, MA ;
Seeger, JD ;
Robins, JM ;
Wolfe, F .
LANCET, 2002, 359 (9313) :1173-1177
[5]   Methotrexate regulates ICAM-1 expression in recipients of rat cardiac allografts [J].
Ciesielski, CJ ;
Pflug, JJ ;
Mei, J ;
Piccinini, LA .
TRANSPLANT IMMUNOLOGY, 1998, 6 (02) :111-121
[6]   Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis [J].
Cutolo, M ;
Sulli, A ;
Pizzorni, C ;
Seriolo, B ;
Straub, RH .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (08) :729-735
[7]   A proteasome inhibitor reduces concurrent, sequential, and long-term IL-1β- and TNF-α-induced ECAM expression and adhesion [J].
Dagia, NM ;
Goetz, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (04) :C813-C822
[8]   Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy [J].
Dahlman-Ghozlan, K ;
Ortonne, JP ;
Heilborn, JD ;
Stephansson, E .
EXPERIMENTAL DERMATOLOGY, 2004, 13 (02) :65-69
[9]   Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease [J].
Duell, PB ;
Malinow, MR .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (01) :28-34
[10]   MONOCYTE ENDOTHELIAL-CELL INTERACTIONS IN-VITRO, WITH REFERENCE TO THE INFLUENCE OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR [J].
FAN, JL ;
SHIMOKAMA, T ;
HARAOKA, S ;
TOKUNAGA, O ;
WATANABE, T .
BIOLOGY OF THE CELL, 1993, 79 (01) :17-26